Evidence map›Paper›PMID 41596079›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Inhibition of Low-Density Lipoprotein Oxidation by Cysteamine, Cystamine, Cysteine and Cystine at Lysosomal pH and pH 7.4.

Emily J Parkes, Ana M Cruz, Amanpreet Kaur, Georgina R Clark, Thomas E Pulford, Christopher Ness, Feroz Ahmad, Yichuan Wen, David S Leake

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emily J ParkesSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.
Ana M CruzSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.ORCID 0000-0002-9290-6752
Amanpreet KaurSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.ORCID 0000-0003-0818-0643
Georgina R ClarkSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.ORCID 0009-0002-4078-886X
Thomas E PulfordSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.
Christopher NessSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.
Feroz AhmadSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.ORCID 0000-0002-2512-9420
Yichuan WenSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.
David S LeakeSchool of Biological Sciences and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading RG6 6UR, UK.ORCID 0000-0002-1742-6134

Funding

British Heart Foundation PG/10/016, PG/15/98/31864 and PG/20/10072
6 · The paper itself

Abstract

LDL can be oxidised in the lysosomes of macrophages. Cysteamine, a thiol antioxidant that accumulates in lysosomes, inhibits the oxidation of LDL by iron at lysosomal pH (pH 4.5) and protects against atherosclerosis in mice. We have investigated the effects of cysteamine and its related thiol cysteine and their disulfides on LDL oxidation by iron or copper at both pH 4.5 and 7.4. The oxidation of LDL by ferrous iron (5 µM) at pH 4.5 was delayed 12.9-fold by 100 µM cysteamine and 5.6-fold by 100 µM cysteine. Cystamine and cystine (the disulfide oxidation products of cyteamine and cysteine, respectively) did not inhibit LDL oxidation by ferrous iron at pH 4.5. LDL oxidation by 5 µM copper at pH 4.5 was delayed about 2-fold by 100 µM of the thiols cysteamine and cysteine, but there was little effect of the disulfides cystamine and cystine. Cysteamine and cystine did not inhibit the oxidation of LDL by ferrous iron at pH 7.4 in a MOPS buffer and even accelerated LDL oxidation later in the incubation. Cysteine initially inhibited the oxidation of LDL by ferrous iron at pH 7.4, but increased it later. LDL oxidation by copper at pH 7.4 was delayed 7.8-fold by 100 µM cysteamine. Cysteine delayed LDL oxidation by copper at pH 7.4 to a similar extent as cysteamine but, unlike cysteamine, continued to decrease the rate of oxidation even after the period of total inhibition had ended. Cystamine had no effect on LDL oxidation by copper at pH 7.4, but cystine partially inhibited LDL oxidation. The effects of thiols and disulfides on LDL oxidation, therefore, depend not only on the metal ion catalysing the oxidation but also on the pH of the environment.

Indexed as

atherosclerosiscystaminecysteaminefoam cellsLDL oxidationlysosomes

Identifiers

PMID41596079
PMCPMC12837393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.